Adult Kidney Disease: Patients on Erythropoiesis-Stimulating Agent-Hemoglobin Level > 12.0 g/dL

INACTIVE REVIEW: This measure review is older than five years.

Percentage of calendar months within a 12-month period during which a Hemoglobin is measured for patients aged 18 years and older with a diagnosis of advanced CKD (stage 4 or 5, not receiving RRT) or ESRD (who are on hemodialysis or peritoneal dialysis) who are also receiving ESA therapy and have a Hemoglobin Level > 12.0 g/dL

Date Reviewed: November 23, 2013
Do Not Support
    Group/Practice Individual Clinician

Measure Info

NQF 1666 NQF Endorsement Removed
Measure Type
Outcome
Measure Steward
Renal Physicians Association
Clinical Topic Area
Chronic Kidney Disease
Care Setting
Home Care
Outpatient
Post-Acute Care
Data Source
Claims
Electronic Health Records
Registry

ACP does not support NQF 1668: “Laboratory Testing (Lipid Profile).” The ACP guideline states that there is inconclusive evidence for periodic monitoring (i.e. lipid profile) in patients diagnosed with stage 1-3 CKD.